United States Postmenopausal Vaginal Atrophy Treatment Market by Manufacturers, States, Type and Application, Forecast to 2022

Choose Licence

 

Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase. Scope of the Report: This report focuses on the Postmenopausal Vaginal Atrophy Treatment in United States market, to split the market based on manufacturers, states, type and application. Market Segment by Manufacturers, this report covers Pfizer Allergan Shionogi Novo Nordisk Teva Pharmaceutical Bayer. Market Segment by States, covering California Texas New York Florida Illinois Market Segment by Type, covers Creams Tablets Patches Rings Market Segment by Applications, can be divided into Topical Estrogen Systemic Estrogen Non-hormonal Therapy There are 17 Chapters to deeply display the United States Postmenopausal Vaginal Atrophy Treatment market. Chapter 1, to describe Postmenopausal Vaginal Atrophy Treatment Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Postmenopausal Vaginal Atrophy Treatment, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Postmenopausal Vaginal Atrophy Treatment, for each state, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications; Chapter 12, Postmenopausal Vaginal Atrophy Treatment market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 15, to describe sales channel, distributors, traders, dealers etc. Chapter 16 and 17, to describe Postmenopausal Vaginal Atrophy Treatment Research Findings and Conclusion, Appendix, methodology and data source.

 

Table of Contents 1 Market Overview 1.1 Postmenopausal Vaginal Atrophy Treatment Introduction 1.2 Market Analysis by Type 1.2.1 Creams 1.2.2 Tablets 1.2.3 Patches 1.2.4 Rings 1.3 Market Analysis by Applications 1.3.1 Topical Estrogen 1.3.2 Systemic Estrogen 1.3.3 Non-hormonal Therapy 1.4 Market Analysis by States 1.4.1 California Status and Prospect (2012-2022) 1.4.2 Texas Status and Prospect (2012-2022) 1.4.3 New York Status and Prospect (2012-2022) 1.4.4 Florida Status and Prospect (2012-2022) 1.4.5 Illinois Status and Prospect (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Pfizer 2.1.1 Profile 2.1.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.4 Business Overview 2.1.5 Pfizer News 2.2 Allergan 2.2.1 Profile 2.2.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.4 Business Overview 2.2.5 Allergan News 2.3 Shionogi 2.3.1 Profile 2.3.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.4 Business Overview 2.3.5 Shionogi News 2.4 Novo Nordisk 2.4.1 Profile 2.4.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.4 Business Overview 2.4.5 Novo Nordisk News 2.5 Teva Pharmaceutical 2.5.1 Profile 2.5.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5.4 Business Overview 2.5.5 Teva Pharmaceutical News 2.6 Bayer. 2.6.1 Profile 2.6.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6.4 Business Overview 2.6.5 Bayer. News 3 United States Postmenopausal Vaginal Atrophy Treatment Market Competition, by Manufacturer 3.1 United States Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Manufacturer (2016-2017) 3.2 United States Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Manufacturer (2016-2017) 3.3 United States Postmenopausal Vaginal Atrophy Treatment Price by Manufacturers (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share 3.4.2 Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share 3.5 Market Competition Trend 4 United States Postmenopausal Vaginal Atrophy Treatment Market Analysis by States 4.1 United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by States 4.2 United States Postmenopausal Vaginal Atrophy Treatment Sales by States (2012-2017) 4.3 United States Postmenopausal Vaginal Atrophy Treatment Revenue (Value) by States (2012-2017) 5 United States Market Segmentation Postmenopausal Vaginal Atrophy Treatment by Type 5.1 United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share by Type (2012-2017) 5.1.1 United States Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type (2012-2017) 5.1.2 United States Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Type (2012-2017) 5.2 Creams Sales Growth and Price 5.2.1 United States Creams Sales Growth (2012-2017) 5.2.2 United States Creams Price (2012-2017) 5.3 Tablets Sales Growth and Price 5.3.1 United States Tablets Sales Growth (2012-2017) 5.3.2 United States Tablets Price (2012-2017) 5.4 Patches Sales Growth and Price 5.4.1 United States Patches Sales Growth (2012-2017) 5.4.2 United States Patches Price (2012-2017) 5.5 Rings Sales Growth and Price 5.5.1 United States Rings Sales Growth (2012-2017) 5.5.2 United States Rings Price (2012-2017) 6 United States Market Segmentation Postmenopausal Vaginal Atrophy Treatment by Application 6.1 United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017) 6.2 Topical Estrogen Sales Growth (2012-2017) 6.3 Systemic Estrogen Sales Growth (2012-2017) 6.4 Non-hormonal Therapy Sales Growth (2012-2017) 7 California Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers 7.1 California Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017) 7.2 California Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type 7.3 California Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) 8 New York Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers 8.1 New York Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017) 8.2 New York Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type 8.3 New York Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) 9 Texas Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers 9.1 Texas Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017) 9.2 Texas Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type 9.3 Texas Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) 10 Florida Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers 10.1 Florida Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017) 10.2 Florida Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type 10.3 Florida Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) 11 Illinois Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers 11.1 Illinois Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017) 11.2 Illinois Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type 11.3 Illinois Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) 12 Postmenopausal Vaginal Atrophy Treatment Market Forecast (2017-2022) 12.1 United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Growth Rate (2017-2022) 12.2 Postmenopausal Vaginal Atrophy Treatment Market Forecast by States (2017-2022) 12.3 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Type (2017-2022) 12.4 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Application (2017-2022) 13 Postmenopausal Vaginal Atrophy Treatment Manufacturing Cost Analysis 13.1 Postmenopausal Vaginal Atrophy Treatment Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Price Trend of Key Raw Materials 13.1.3 Key Suppliers of Raw Materials 13.1.4 Market Concentration Rate of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.2.1 Raw Materials 13.2.2 Labor Cost 13.2.3 Manufacturing Expenses 13.3 Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Treatment 14 Industrial Chain, Sourcing Strategy and Downstream Buyers 14.1 Postmenopausal Vaginal Atrophy Treatment Industrial Chain Analysis 14.2 Upstream Raw Materials Sourcing 14.3 Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Manufacturers in 2016 14.4 Downstream Buyers 15 Sales Channel, Distributors, Traders and Dealers 15.1 Sales Channel 15.1.1 Direct Marketing 15.1.2 Indirect Marketing 15.1.3 Marketing Channel Future Trend 15.2 Distributors, Traders and Dealers 16 Research Findings and Conclusion 17 Appendix 17.1 Methodology 17.2 Analyst Introduction 17.3 Data Source

List of Tables and Figures Figure Postmenopausal Vaginal Atrophy Treatment Picture Table Product Specifications of Postmenopausal Vaginal Atrophy Treatment Figure United States Sales Market Share of Postmenopausal Vaginal Atrophy Treatment by Types in 2016 Table Types of Postmenopausal Vaginal Atrophy Treatment Figure Creams Picture Table Major Manufacturers of Creams Figure Tablets Picture Table Major Manufacturers of Tablets Figure Patches Picture Table Major Manufacturers of Patches Figure Rings Picture Table Major Manufacturers of Rings Table United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Applications in 2016 Table Applications of Postmenopausal Vaginal Atrophy Treatment Figure Topical Estrogen Picture Figure Systemic Estrogen Picture Figure Non-hormonal Therapy Picture Figure California Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure Texas Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure New York Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure Florida Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure Illinois Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Postmenopausal Vaginal Atrophy Treatment Type and Applications Table Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Allergan Basic Information, Manufacturing Base and Competitors Table Allergan Postmenopausal Vaginal Atrophy Treatment Type and Applications Table Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Shionogi Basic Information, Manufacturing Base and Competitors Table Shionogi Postmenopausal Vaginal Atrophy Treatment Type and Applications Table Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novo Nordisk Basic Information, Manufacturing Base and Competitors Table Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Type and Applications Table Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Type and Applications Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bayer. Basic Information, Manufacturing Base and Competitors Table Bayer. Postmenopausal Vaginal Atrophy Treatment Type and Applications Table Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Manufacturer (2016-2017) Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2016 Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2017 Table United States Postmenopausal Vaginal Atrophy Treatment Revenue by Manufacturer (2016-2017) Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2015 Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2016 Table United States Postmenopausal Vaginal Atrophy Treatment Price by Manufacturers (2016-2017) Figure Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2016 Figure Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2017 Figure Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2016 Figure Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2017 Figure United States Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Sales by States (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by States (2012-2017) Figure United States 2012 Postmenopausal Vaginal Atrophy Treatment Sales Market Share by States Figure United States 2016 Postmenopausal Vaginal Atrophy Treatment Sales Market Share by States Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Revenue by States (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by States (2012-2017) Table United States 2012 Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by States Table United States 2016 Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by States Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Sales Share by Type (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Revenue Share by Type (2012-2017) Figure United States Creams Sales Growth (2012-2017) Figure United States Creams Price (2012-2017) Figure United States Tablets Sales Growth (2012-2017) Figure United States Tablets Price (2012-2017) Figure United States Patches Sales Growth (2012-2017) Figure United States Patches Price (2012-2017) Figure United States Rings Sales Growth (2012-2017) Figure United States Rings Price (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Sales Share by Application (2012-2017) Figure United States Topical Estrogen Sales Growth (2012-2017) Figure United States Systemic Estrogen Sales Growth (2012-2017) Figure United States Non-hormonal Therapy Sales Growth (2012-2017) Figure California Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017) Figure California Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017) Table California Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017) Table California Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017) Table California Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) Table California Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017) Figure New York Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017) Figure New York Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017) Table New York Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017) Table New York Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017) Table New York Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) Table New York Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017) Figure Texas Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017) Figure Texas Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017) Table Texas Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017) Table Texas Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017) Table Texas Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) Table Texas Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017) Figure Florida Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017) Figure Florida Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017) Table Florida Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017) Table Florida Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017) Table Florida Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) Table Florida Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017) Figure Illinois Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017) Figure Illinois Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017) Table Illinois Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017) Table Illinois Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017) Table Illinois Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) Table Illinois Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017) Figure United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Growth Rate (2017-2022) Table United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast by States (2017-2022) Table United States Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by States (2017-2022) Table United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Type (2017-2022) Table United States Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by Type (2017-2022) Table United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Application (2017-2022) Table United States Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by Application (2017-2022) Table Sales Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Postmenopausal Vaginal Atrophy Treatment Figure Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Treatment Figure Postmenopausal Vaginal Atrophy Treatment Industrial Chain Analysis Table Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Manufacturers in 2016 Table Major Buyers of Postmenopausal Vaginal Atrophy Treatment Table Distributors/Traders/ Dealers List

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Other Reports by GlobalInfoResearch

China Gluconic Acid (Cas 526-95-4) Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

"Gluconic acid is derived from glucose through a simple dehydrogenation reaction. It is a multifunctional organic acid used as bulk chemical in the food, feed, pharmaceutical, textile, metallurgy, detergent and construction industries. Gluconic acid ...

China Food for Special Medical Purpose (FSMP) Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

Foods for special medical purposes (FSMP) are a sub-category of foods intended for particular nutritional uses (PARNUT), also called ?dietetic foods.? FSMPs are intended for the dietary management of diseases in patients with impaired digestive funct...

China Fibrinogen Concentrate Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled pla...

China Commercial Microwave Ovens Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

This report studies the Commercial Microwave Ovens market; Commercial microwaves are constructed with higher quality materials and designed for superior durability compared to a typical residential microwave. They are also designed for much more freq...

China Chemical Polishing Slurry Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

Chemical Polishing Slurry is a type of slurry product that using the chemical method (either electroltic or e-less deposition) to reach polishing effect, rather than the mechanical method. Scope of the Report: This report focuses on the Chemica...

New Pharmaceuticals and Healthcare Reports